J. B. Schwartz, The influence of sex on pharmacokinetics, Clin Pharmacokinet, 2003.

A. M. Berg and M. J. , Biologic and molecular mechanisms for sex differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics: Part I, J Womens Health Gend Based Med, vol.11, pp.601-616, 2002.

J. Bearak, A. Popinchalk, L. Alkema, and G. Sedgh, Global, regional, and subregional trends in unintended pregnancy and its outcomes from 1990 to 2014: estimates from a Bayesian hierarchical model, Lancet Glob Health, vol.6, pp.380-389, 2018.

, Committee Opinion No. 646: Ethical Considerations for Including Women as Research Participants, Obstet Gynecol, vol.127, pp.1127-1135, 2016.

, Clinical Trial Facilitation Group. Recommendations related to contraception and

G. Gastaminza-lasarte, A. Pineda, and J. , Descriptive study on contraceptive requirements for clinical trials in Spain

, Med Clin (Barc), vol.132, pp.70-74, 2009.

A. L. Phelan, A. R. Kunselman, C. H. Chuang, N. T. Raja-khan, and R. S. Legro, Exclusion of Women of Childbearing Potential in Clinical Trials of Type 2 Diabetes Medications: A Review of Protocol-Based Barriers to Enrollment, Diabetes Care, vol.39, pp.1004-1013, 2016.

M. Vieira, P. Stratton, and C. Gonzalez, A Systematic Review of Inclusion of Women of Childbearing Potential (WOCP) in NIH Clinical Trials: Contraception and Pregnancy Testing, AER Conference: Navigating the Future Using the Belmont Compass, 2009.

. Nashville,

J. Stewart, W. J. Breslin, and B. K. Beyer, Birth Control in Clinical Trials: Industry Survey of Current Use Practices, Governance, and Monitoring, Ther Innov Regul Sci, vol.50, pp.155-68, 2016.

S. Sibeko, C. Baxter, N. Yende, K. Qa, and S. S. Karim, Contraceptive choices, pregnancy rates, and outcomes in a microbicide trial, Obstet Gynecol, vol.118, pp.895-904, 2011.

C. A. Akello, K. E. Bunge, and C. Nakabiito, Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial, J Womens Health, 2017.